• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Imprimis Pharmaceuticals Inc

+ Add to Watchlist

IMMY:US

6.9800 USD 0.3300 4.51%

As of 20:10:00 ET on 01/23/2015.

Snapshot for Imprimis Pharmaceuticals Inc (IMMY)

Open: 7.2600 Day's Range: 6.9500 - 7.9990 Volume: 43,143
Previous Close: 7.3100 52wk Range: 4.7100 - 9.6200 1-Yr Rtn: -3.72%

Stock Chart for IMMY

No chart data available.
  • IMMY:US 6.9800
  • 1D
  • 1M
  • 1Y
7.3100
Interactive IMMY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IMMY

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.0200
Est. EPS (USD) (12/2014) -1.0900
Est. PEG Ratio -
Market Cap (M USD) 64.60
Shares Outstanding (M) 9.26
30 Day Average Volume 14,863
Price/Book (mrq) 6.2759
Price/Sale (ttm) 57.2567
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IMMY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IMMY

Imprimis Pharmaceuticals, Inc. is a pharmaceutical company that focuses on the development and commercialization of non-invasive topically delivered medications.

Mark L BaumChief Executive OfficerAndrew R BollVP:Accounting
More Company Profile & Key Executives for IMMY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil